PERIPHERAL VEIN THROMBUS EXTENSION

This adverse event was reported 39 times

These drugs are most commonly taken by patients reporting PERIPHERAL VEIN THROMBUS EXTENSION:

# Drug Count
0 POLIDOCANOL 28
1 DEXAMETHASONE 3
2 DEXAMETHASONE 1.5 MG 3
3 GUANFACINE 2
4 HUMAN IMMUNOGLOBULIN G 2
5 LEVONORGESTREL 2
6 ROMIPLOSTIM 2
7 SERTRALINE 2
8 ACETAMINOPHEN 1
9 ACETAMINOPHEN 500MG 1
See all common drugs associated with PERIPHERAL VEIN THROMBUS EXTENSION

PERIPHERAL VEIN THROMBUS EXTENSION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 POLIDOCANOL 28 0.0189
1 CAPLACIZUMAB 1 0.0006
2 CODEINE SULFATE 1 0.0003
3 GUANFACINE 2 0.0002
4 NORETHINDRONE 1 0.0002
5 ROMIPLOSTIM 2 0.0001
6 HUMAN IMMUNOGLOBULIN G 2 0.0001
7 PEGASPARGASE 1 0.0001
8 INSTALAX POLYETHYLENE GLYCOL 3350 1 0.0001
9 POLYETHYLENE GLYCOL 400 1 0.0001
See all drugs enriched for association with PERIPHERAL VEIN THROMBUS EXTENSION

PERIPHERAL VEIN THROMBUS EXTENSION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Thrombopoietin Receptor Agonist [EPC] 2 0.0001
1 Human Immunoglobulin G [EPC] 2 0.0001
2 Asparagine-specific Enzyme [EPC] 1 0.0001
3 Provitamin D2 Compound [EPC] 1 0.0000
4 Progestin [EPC] 3 0.0000
5 Nucleoside Metabolic Inhibitor [EPC] 2 0.0000
6 Janus Kinase Inhibitor [EPC] 1 0.0000
7 Platinum-based Drug [EPC] 1 0.0000
8 Proton Pump Inhibitor [EPC] 2 0.0000
9 Osmotic Laxative [EPC] 1 0.0000
See all drug classes enriched for association with PERIPHERAL VEIN THROMBUS EXTENSION